Sign in
4

Changes in Ownership

ALX ONCOLOGY HOLDINGS INC Filed Acc 0001415889-24-011128

PRESIDENT & CSO sold 50,000 shares at $14.20 ($710,195)

  • PRESIDENT & CSO acquired 25,846 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Pons Jaume PRESIDENT & CSO 2024-04-16 Option exercise 10b5-1 +25,846 $0.99 $25,588 654,205 D: show line 1 in the form
Pons Jaume PRESIDENT & CSO 2024-04-16 Sale 10b5-1 −50,000 $14.20 $710,195 604,205 D: show line 2 in the form
Open-market sales · 50,000 sh · avg $14.20 · $710,195

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Pons Jaume PRESIDENT & CSO 2024-04-16 Option exercise · Employee Stock Option (right to buy) 10b5-1 −25,846 204,433 D: show line 3 in the form
Loading xslF345X05/form4-04182024_080417.xml…